Breaking the BioPharma paradox of cutting-edge science and lagging digital transformation
We are living in a century that has witnessed huge advancements in technology, with more than half of the world’s population now having internet access through a device they keep in their pocket.
Equally, the revolution in molecular biology brings a new frontier in the fight against some of the most devastating illnesses affecting humankind.
Over the last decade, leading innovators across academia and industry have been realising the potential of this new generation of biopharmaceutical medicines (biologics) to positively impact the lives of thousands of patients across the globe.
Check out the rest of this feature here